Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Novocure GmbH - The evolving role of TTFields therapy in solid tumors

Fireside chat

Date

23 Oct 2023

Session

Novocure GmbH - The evolving role of TTFields therapy in solid tumors

Topics

Therapy

Tumour Site

Ovarian Cancer;  Non-Small Cell Lung Cancer;  Central Nervous System Malignancies;  Pancreatic Adenocarcinoma

Presenters

All Speakers

Authors

J. Sehouli1, J.G. Aerts2, S. Rieken3, T. Macarulla4, A. Speakers5

Author affiliations

  • 1 Gynecology, Charité - Universitaetsmedizin Berlin, 13353 - Berlin/DE
  • 2 Respiratory Medicine, Erasmus MC - University Medical Center, 3015 CE - Rotterdam/NL
  • 3 Radiation Oncology, Universitätsmedizin Göttingen, 37075 - Goettingen/DE
  • 4 Medical Oncology Dept., Vall d'Hebron Institute of Oncology (VHIO)-Cellex Center, 8035 - Barcelona/ES
  • 5 ESMO - European Society for Medical Oncology, GX11 1AA - Lugano/CH

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome

Presenter: Joachim Aerts

Session: Novocure GmbH - The evolving role of TTFields therapy in solid tumors

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.